Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

摘要

There is provided a compound of formula I: or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.